Most bought healthcare stocks in Q3 2024
See which Healthcare stocks institutional investors increased the most in Q3 2024, measured as net growth in reported share positions from Q2 2024 into Q3 2024. Notable additions at the top of this list include BAXTER INTERNATIONAL INC (BAX), TEVA PHARMACEUTICAL-SP ADR (TEVA), RECURSION PHARMACEUTICALS-A (RXRX), AVANTOR INC (AVTR). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BAX | BAXTER INTERNATIONAL INC | 18,471,786 | $976.41M | 0 | 5 | 2 | 0 | 8 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 6,122,581 | $138.26M | 1 | 1 | 3 | 0 | 6 |
| RXRX | RECURSION PHARMACEUTICALS-A | 4,626,268 | $4.88M | 0 | 1 | 0 | 0 | 1 |
| AVTR | AVANTOR INC | 4,058,977 | $470.66M | 1 | 3 | 3 | 0 | 7 |
| CVS | CVS HEALTH CORP | 3,963,740 | $549.74M | 2 | 4 | 7 | 0 | 13 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,947,337 | -$47.20M | 1 | 2 | 1 | 1 | 4 |
| OPCH | OPTION CARE HEALTH INC | 2,419,138 | $77.04M | 2 | 1 | 1 | 0 | 4 |
| PRVA | PRIVIA HEALTH GROUP INC | 2,221,062 | $48.07M | 0 | 3 | 0 | 0 | 3 |
| SYK | STRYKER CORP | 2,022,263 | $924.34M | 2 | 3 | 3 | 0 | 8 |
| TEM | TEMPUS AI INC | 1,855,459 | $116.31M | 0 | 1 | 0 | 0 | 1 |
| ELEV | ELEVATION ONCOLOGY INC | 1,785,982 | $1.07M | 1 | 0 | 0 | 0 | 1 |
| SOLV | SOLVENTUM CORP | 1,777,879 | $215.21M | 1 | 2 | 1 | 0 | 6 |
| DOCS | DOXIMITY INC-CLASS A | 1,580,142 | $192.50M | 0 | 2 | 0 | 1 | 2 |
| GH | GUARDANT HEALTH INC | 1,497,504 | $31.66M | 1 | 1 | 0 | 0 | 2 |
| ALHC | ALIGNMENT HEALTHCARE INC | 1,464,579 | $39.50M | 0 | 1 | 1 | 0 | 2 |
| WRBY | WARBY PARKER INC-CLASS A | 1,423,134 | $25.64M | 0 | 3 | 1 | 0 | 4 |
| NVST | ENVISTA HOLDINGS CORP | 1,419,331 | $66.95M | 0 | 1 | 2 | 0 | 3 |
| VREX | VAREX IMAGING CORP | 1,278,667 | $6.34M | 0 | 1 | 2 | 0 | 3 |
| MRK | MERCK & CO. INC. | 1,233,091 | $121.11M | 0 | 4 | 4 | 2 | 12 |
| EW | EDWARDS LIFESCIENCES CORP | 1,228,525 | $68.82M | 2 | 3 | 1 | 0 | 7 |
| TXG | 10X GENOMICS INC-CLASS A | 1,226,382 | $57.50M | 0 | 1 | 0 | 1 | 1 |
| BSX | BOSTON SCIENTIFIC CORP | 1,224,858 | $103.64M | 2 | 3 | 1 | 0 | 6 |
| ABCL | ABCELLERA BIOLOGICS INC | 1,218,100 | $2.54M | 0 | 1 | 0 | 0 | 1 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 1,207,600 | $21.33M | 0 | 1 | 0 | 0 | 1 |
| XRAY | DENTSPLY SIRONA INC | 1,176,373 | $61.36M | 1 | 3 | 0 | 0 | 4 |
| ADMA | ADMA BIOLOGICS INC | 1,085,061 | $44.44M | 0 | 1 | 0 | 0 | 1 |
| NVAX | NOVAVAX INC | 954,600 | $12.02M | 0 | 1 | 0 | 0 | 1 |
| ASRT | ASSERTIO HOLDINGS INC | 856,309 | $867.79K | 0 | 1 | 0 | 0 | 1 |
| HUM | HUMANA INC | 853,543 | -$157.87M | 0 | 5 | 0 | 2 | 5 |
| ABSI | ABSCI CORP | 833,734 | $7.26M | 0 | 1 | 0 | 0 | 1 |
| MYGN | MYRIAD GENETICS INC | 805,481 | $28.18M | 1 | 1 | 0 | 0 | 2 |
| BAYRY | BAYER AG-SPONSORED ADR | 785,085 | $12.91M | 0 | 1 | 0 | 0 | 1 |
| BDX | BECTON DICKINSON AND CO | 771,681 | $209.19M | 1 | 6 | 1 | 0 | 10 |
| FGEN | FIBROGEN INC | 753,140 | $300.80K | 1 | 0 | 0 | 0 | 1 |
| SGMO | SANGAMO THERAPEUTICS INC | 726,200 | $2.72M | 0 | 1 | 0 | 0 | 1 |
| CNC | CENTENE CORP | 712,378 | $61.38M | 1 | 1 | 1 | 0 | 3 |
| OGN | ORGANON & CO | 646,828 | $2.02M | 0 | 4 | 0 | 0 | 4 |
| BMY | BRISTOL-MYERS SQUIBB CO | 639,855 | $364.51M | 1 | 5 | 5 | 0 | 12 |
| MNKD | MANNKIND CORP | 638,800 | $4.05M | 0 | 1 | 0 | 0 | 2 |
| PSNL | PERSONALIS INC | 625,437 | $34.48M | 0 | 1 | 1 | 0 | 2 |
| NTLA | INTELLIA THERAPEUTICS INC | 620,951 | -$8.53M | 0 | 1 | 0 | 1 | 1 |
| TALK | TALKSPACE INC | 561,600 | $866.93K | 1 | 1 | 0 | 0 | 2 |
| KZR | KEZAR LIFE SCIENCES INC | 518,600 | $535.81K | 0 | 1 | 0 | 0 | 1 |
| NTRA | NATERA INC | 512,410 | $77.30M | 0 | 4 | 0 | 0 | 4 |
| NVRO | NEVRO CORP | 505,819 | -$3.55M | 0 | 1 | 1 | 0 | 2 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 485,180 | $374.26K | 0 | 1 | 0 | 0 | 1 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 475,532 | $40.46M | 0 | 5 | 5 | 0 | 10 |
| ACRS | ACLARIS THERAPEUTICS INC | 448,500 | $561.88K | 0 | 1 | 0 | 0 | 1 |
| CRDF | CARDIFF ONCOLOGY INC | 444,894 | $1.26M | 0 | 1 | 0 | 0 | 1 |
| BKD | BROOKDALE SENIOR LIVING INC | 439,918 | $2.70M | 0 | 2 | 0 | 0 | 2 |
Frequently asked questions about Most bought healthcare stocks in Q3 2024
What are the most bought Healthcare stocks in Q3 2024?
The most bought healthcare stocks in Q3 2024 are those with the largest increase in reported share counts across tracked institutional investors compared to Q2 2024, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q3 2024?
Among the managers we track, net additions were largest in companies such as BAXTER INTERNATIONAL INC (BAX), TEVA PHARMACEUTICAL-SP ADR (TEVA), RECURSION PHARMACEUTICALS-A (RXRX), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q2 2024).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.